Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer’s disease and frontotemporal dementia

Carol L. Nilsson, Ann Brinkmalm, Lennart Minthon, +2

Peptides

Neurodegenerative DiseasesAlzheimer's DiseaseNeurobiology Of DiseaseCerebrospinal FluidDementia +8

Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in Sweden

Niels Andreasen, Kaj Blennow, Christina Sjödin, +2

Neuroepidemiology

Geriatric PsychiatryNeuropsychologyAgingMemory ImpairmentsPiteå River Valley +25

Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study

Yihua Ma, Carly M. Farris, Sandrina Weber, +30

The Lancet Neurology

EngineeringMulticentre Cohort StudyMultiple System AtrophyGenetic EpidemiologyDiagnosis +7

Increased cerebrospinal fluid protein tau concentration in neuro-AIDS

Lars-Magnus Andersson, Kaj Blennow, Dietmar Fuchs, +2

Journal of the Neurological Sciences

Neurodegenerative DiseasesNeurovirologyMedicineCerebrospinal FluidNeurology +3

The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-β positivity

Burak Arslan, Wagner S. Brum, Ilaria Pola, +18

Alzheimer s Research & Therapy

Machine learning prediction of tau‐PET in Alzheimer's disease using plasma, MRI, and clinical data

Linda Karlsson, Jacob W. Vogel, Ida Arvidsson, +17

Alzheimer s & Dementia

A head‐to‐head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic

Federica Anastasi, Aida Fernández‐Lebrero, Nicholas J. Ashton, +24

Alzheimer s & Dementia

Plasma p‐tau ₂₁₇ and neurofilament/p‐tau ₂₁₇ ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

Alberto Benussi, Hanna Huber, Kübra Tan, +8

Alzheimer s & Dementia

The potential dual role of tau phosphorylation: plasma phosphorylated-tau217 in newborns and Alzheimer’s disease

Fernando González‐Ortiz, Jakub Vávra, Emma Payne, +14

Brain Communications

Plasma phosphorylated-tau217 is increased in Niemann–Pick disease type C

Fernando González‐Ortiz, Thomas K. Karikari, Daniëlle te Vruchte, +5

Brain Communications